141 related articles for article (PubMed ID: 26998113)
1. BCL9, a coactivator for Wnt/β-catenin transcription, is targeted by miR-30c and is associated with prostate cancer progression.
Ling XH; Chen ZY; Luo HW; Liu ZZ; Liang YK; Chen GX; Jiang FN; Zhong WD
Oncol Lett; 2016 Mar; 11(3):2001-2008. PubMed ID: 26998113
[TBL] [Abstract][Full Text] [Related]
2. Endometrial epithelial cells-derived exosomes deliver microRNA-30c to block the BCL9/Wnt/CD44 signaling and inhibit cell invasion and migration in ovarian endometriosis.
Zhang M; Wang X; Xia X; Fang X; Zhang T; Huang F
Cell Death Discov; 2022 Apr; 8(1):151. PubMed ID: 35368023
[TBL] [Abstract][Full Text] [Related]
3. MiR-30c exerts tumor suppressive functions in colorectal carcinoma by directly targeting BCL9.
Zhao DW; Li MM; Han JP; Wang Y; Jiang LX; Chang HL
Eur Rev Med Pharmacol Sci; 2019 Apr; 23(8):3335-3343. PubMed ID: 31081087
[TBL] [Abstract][Full Text] [Related]
4. MicroRNA-30c serves as an independent biochemical recurrence predictor and potential tumor suppressor for prostate cancer.
Ling XH; Han ZD; Xia D; He HC; Jiang FN; Lin ZY; Fu X; Deng YH; Dai QS; Cai C; Chen JH; Liang YX; Zhong WD; Wu CL
Mol Biol Rep; 2014 May; 41(5):2779-88. PubMed ID: 24452717
[TBL] [Abstract][Full Text] [Related]
5. MicroRNA-30c-2* expressed in ovarian cancer cells suppresses growth factor-induced cellular proliferation and downregulates the oncogene BCL9.
Jia W; Eneh JO; Ratnaparkhe S; Altman MK; Murph MM
Mol Cancer Res; 2011 Dec; 9(12):1732-45. PubMed ID: 22024689
[TBL] [Abstract][Full Text] [Related]
6. MicroRNA-939 Directly Targets
Situ J; Zhang H; Jin Z; Li K; Mao Y; Huang W
Onco Targets Ther; 2020; 13():4257-4270. PubMed ID: 32547060
[TBL] [Abstract][Full Text] [Related]
7. Downregulation of miR-1266-5P, miR-185-5P and miR-30c-2 in prostatic cancer tissue and cell lines.
Ostadrahimi S; Fayaz S; Parvizhamidi M; Abedi-Valugerdi M; Hassan M; Kadivar M; Teimoori-Toolabi L; Asgari M; Shahrokh H; Abolhasani M; Mahdian R; Fard-Esfahani P
Oncol Lett; 2018 May; 15(5):8157-8164. PubMed ID: 29849810
[TBL] [Abstract][Full Text] [Related]
8. miR-1303 promotes the proliferation, migration and invasion of prostate cancer cells through regulating the Wnt/β-catenin pathway by targeting DKK3.
Liu B; Zhou W; Jiang H; Xiang Z; Wang L
Exp Ther Med; 2019 Dec; 18(6):4747-4757. PubMed ID: 31772644
[TBL] [Abstract][Full Text] [Related]
9. MicroRNA-320 suppresses the stem cell-like characteristics of prostate cancer cells by downregulating the Wnt/beta-catenin signaling pathway.
Hsieh IS; Chang KC; Tsai YT; Ke JY; Lu PJ; Lee KH; Yeh SD; Hong TM; Chen YL
Carcinogenesis; 2013 Mar; 34(3):530-8. PubMed ID: 23188675
[TBL] [Abstract][Full Text] [Related]
10. Expression of miR-30c and miR-29b in prostate cancer and its diagnostic significance.
Zhu C; Hou X; Zhu J; Jiang C; Wei W
Oncol Lett; 2018 Sep; 16(3):3140-3144. PubMed ID: 30127906
[TBL] [Abstract][Full Text] [Related]
11. MicroRNA-744 promotes prostate cancer progression through aberrantly activating Wnt/β-catenin signaling.
Guan H; Liu C; Fang F; Huang Y; Tao T; Ling Z; You Z; Han X; Chen S; Xu B; Chen M
Oncotarget; 2017 Feb; 8(9):14693-14707. PubMed ID: 28107193
[TBL] [Abstract][Full Text] [Related]
12. SOX7 Suppresses Wnt Signaling by Disrupting β-Catenin/BCL9 Interaction.
Fan R; He H; Yao W; Zhu Y; Zhou X; Gui M; Lu J; Xi H; Deng Z; Fan M
DNA Cell Biol; 2018 Feb; 37(2):126-132. PubMed ID: 29271667
[TBL] [Abstract][Full Text] [Related]
13. [Association of BCL9 expression with prostate cancer clinicopathological features and survival].
He G; Yang S; Chen Y; Cai C; Zhuo Y; Luo H; Cai Z; Jiang F; Ling X
Zhonghua Yi Xue Za Zhi; 2015 Aug; 95(32):2603-6. PubMed ID: 26711608
[TBL] [Abstract][Full Text] [Related]
14. Low expression of microRNA-30c promotes prostate cancer cells invasion involved in downregulation of KRAS protein.
Zhang J; Wang X; Wang Y; Peng R; Lin Z; Wang Y; Hu B; Wang J; Shi G
Oncol Lett; 2017 Jul; 14(1):363-368. PubMed ID: 28693177
[TBL] [Abstract][Full Text] [Related]
15. Epithelial and stromal expression of miRNAs during prostate cancer progression.
Ren Q; Liang J; Wei J; Basturk O; Wang J; Daniels G; Gellert LL; Li Y; Shen Y; Osman I; Zhao J; Melamed J; Lee P
Am J Transl Res; 2014; 6(4):329-39. PubMed ID: 25075250
[TBL] [Abstract][Full Text] [Related]
16. BCL9 Upregulation in Adrenocortical Carcinoma: A Novel Wnt/β-Catenin Activating Event Driving Adrenocortical Malignancy.
Brown TC; Nicolson NG; Korah R; Carling T
J Am Coll Surg; 2018 Jun; 226(6):988-995. PubMed ID: 29428231
[TBL] [Abstract][Full Text] [Related]
17. miR-15a-3p Suppresses Prostate Cancer Cell Proliferation and Invasion by Targeting SLC39A7 Via Downregulating Wnt/β-Catenin Signaling Pathway.
Cui Y; Yang Y; Ren L; Yang J; Wang B; Xing T; Chen H; Chen M
Cancer Biother Radiopharm; 2019 Sep; 34(7):472-479. PubMed ID: 31135177
[No Abstract] [Full Text] [Related]
18. Capn4 expression is modulated by microRNA-520b and exerts an oncogenic role in prostate cancer cells by promoting Wnt/β-catenin signaling.
Ren W; Wang D; Li C; Shu T; Zhang W; Fu X
Biomed Pharmacother; 2018 Dec; 108():467-475. PubMed ID: 30241050
[TBL] [Abstract][Full Text] [Related]
19. Suppression of microRNA-454 impedes the proliferation and invasion of prostate cancer cells by promoting N-myc downstream-regulated gene 2 and inhibiting WNT/β-catenin signaling.
Fu Q; Gao Y; Yang F; Mao T; Sun Z; Wang H; Song B; Li X
Biomed Pharmacother; 2018 Jan; 97():120-127. PubMed ID: 29080452
[TBL] [Abstract][Full Text] [Related]
20. BCL9 promotes epithelial mesenchymal transition and invasion in cisplatin resistant NSCLC cells via β-catenin pathway.
Zhang Y; Zhang Q; Chen H; Wang C
Life Sci; 2018 Sep; 208():284-294. PubMed ID: 30009824
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
